Sign In
Get Clay Free →

Suggestions

    Per Greisen

    Director

    Per Greisen is a seasoned professional with a strong background in computational drug discovery.

    Currently, Per Greisen serves as the Director for Computational Drug Discovery at Novo Nordisk, a prominent pharmaceutical company.

    Prior to his current role, Per Greisen held various positions, including Guest Researcher at Wyss Institute for Biologically Inspired Engineering, Director of Computational Biology at enEvolv, Principal Modelling Scientist, and Specialist at Novo Nordisk.

    Per Greisen began his career as a Senior Postdoctoral Fellow at the University of Washington, showcasing his academic and research excellence.

    With his wealth of experience in different organizations, Per Greisen possesses a diverse skill set and a comprehensive understanding of computational biology and drug discovery.

    His journey from academia to industry has equipped him with a unique perspective on innovative research and development strategies.

    Per Greisen's leadership at Novo Nordisk highlights his expertise in leveraging computational methods to drive drug discovery projects and bring novel therapies to market.

    P
    Add to my network

    Location

    Seattle, Washington, United States